A randomised controlled trial to evaluate the efficacy of a 6 month dietary and physical activity intervention for prostate cancer patients receiving androgen deprivation therapy.
BACKGROUND
Treatment with Androgen Deprivation Therapy (ADT) for prostate cancer is associated with changes in body composition including increased fat and decreased lean mass; increased fatigue, and a reduction in quality of life. No study to date has evaluated the effect of dietary and physical activity modification on the side-effects related to ADT. The aim of this study is to evaluate the efficacy of a 6-month dietary and physical activity intervention for prostate cancer survivors receiving ADT to minimise the changes in body composition, fatigue and quality of life, typically associated with ADT.


METHODS
Men are recruited to this study if their treatment plan is to receive ADT for at least 6 months. Men who are randomised to the intervention arm receive a home-based tailored intervention to meet the following guidelines a) > or = 5 servings vegetables and fruits/day; b) 30%-35% of total energy from fat, and < 10% energy from saturated fat/day; c) 10% of energy from polyunsaturated fat/day; d) limited consumption of processed meats; e) 25-35 gm of fibre/day; f) alcoholic drinks < or = 28 units/week; g) limited intake of foods high in salt and/or sugar. They are also encouraged to include at least 30 minutes of brisk walking, 5 or more days per week. The primary outcomes are change in body composition, fatigue and quality of life scores. Secondary outcomes include dietary intake, physical activity and perceived stress. Baseline information collected includes: socio-economic status, treatment duration, perceived social support and health status, family history of cancer, co-morbidities, medication and supplement use, barriers to change, and readiness to change their health behaviour. Data for the primary and secondary outcomes will be collected at baseline, 3 and 6 months from 47 intervention and 47 control patients.


CONCLUSIONS
The results of this study will provide detailed information on diet and physical activity levels in prostate cancer patients treated with ADT and will test the feasibility and efficacy of a diet and physical activity intervention which could provide essential information to develop guidelines for prostate cancer patients to minimise the side effects related to ADT.


BACKGROUND
ISRCTN trial number ISCRTN75282423.
Haseen
Farhana
F
Centre for Public Health, Queen's University Belfast, Northern Ireland, UK. fhaseen01@qub.ac.uk
Murray
Liam J
LJ
O'Neill
Roisin F
RF
O'Sullivan
Joe M
JM
Cantwell
Marie M
MM
D000428:Alcohol Drinking; D000726:Androgen Antagonists / Q000008:administration & dosage* / Q000009:adverse effects; D001823:Body Composition / Q000187:drug effects*; D003131:Combined Modality Therapy; D015897:Comorbidity; D004041:Dietary Fats / Q000008:administration & dosage; D019422:Dietary Sucrose / Q000008:administration & dosage; D005221:Fatigue / Q000517:prevention & control; D005240:Feasibility Studies; D006801:Humans; D008297:Male; D009043:Motor Activity; D015596:Nutrition Assessment; D010361:Patients; D011471:Prostatic Neoplasms / Q000178:diet therapy* / Q000188:drug therapy* / Q000453:epidemiology; D011788:Quality of Life; D018401:Sample Size; D013315:Stress, Psychological / Q000175:diagnosis
D000726:Androgen Antagonists; D004041:Dietary Fats; D019422:Dietary Sucrose